Some users experience mild nasal irritation, particularly with initial use
The GLP-1 receptor agonist class began with compounds like liraglutide and exenatide, targeting only the GLP-1R
It is generally viewed as a metabolic-support peptide rather than an appetite suppressant
Two severe adverse events were reported: viral meningitis (in cagrilintide 1.2 mg + semaglutide 2.4 mg) and an increase in serum creatinine (in placebo + semaglutide 2.4 mg), but both events were deemed unrelated to study treatment by the study investigator
As their baseline improves, some choose to transition into less frequent appointments
The misplaced endometrial tissue triggers immune system activation, releasing pro-inflammatory cytokines including interleukin-1 beta (IL-1), tumor necrosis factor-alpha (TNF-), and interleukin-6 (IL-6)